Navigation Links
Scripps research scientists find anticonvulsant drug helps marijuana smokers kick the habit
Date:4/24/2012

LA JOLLA, CA April 24, 2012 Scientists at The Scripps Research Institute have found clinical evidence that the drug gabapentin, currently on the market to treat neuropathic pain and epilepsy, helps people to quit smoking marijuana (cannabis). Unlike traditional addiction treatments, gabapentin targets stress systems in the brain that are activated by drug withdrawal.

In a 12-week trial of 50 treatment-seeking cannabis users, those who took gabapentin used less cannabis, experienced fewer withdrawal symptoms such as sleeplessness, and scored higher on tests of attention, impulse-control, and other cognitive skills, compared to patients who received a placebo. If these results are confirmed by ongoing larger trials, gabapentin could become the first FDA-approved pharmaceutical treatment for cannabis dependence.

"A lot of other drugs have been tested for their ability to decrease cannabis use and withdrawal, but this is the first to show these key effects in a controlled treatment study," said Barbara J. Mason, the Pearson Family Chair and Co-Director of the Pearson Center for Alcoholism and Addiction Research at Scripps Research. "The other nice thing about gabapentin is that it is already widely prescribed, so its safety is less likely to be an issue."

Mason led the new gabapentin study, recently published online ahead of print by the journal Neuropsychopharmacology.

Stress Circuits

Addiction researchers have long known that recreational drugs hook users by disrupting the normal tuning of their brains' reward and motivation circuitry. But as scientists at Scripps Research and other institutions have shown in animal studies, cannabis withdrawal after prolonged heavy use also leads to the long-term activation of basic stress circuits. "In human cannabis users who try to quit, this stress response is reflected in reports of drug craving, sleep disturbances, anxiety, irritability, and dysphoria, any o
'/>"/>

Contact: Mika Ono
mikaono@scripps.edu
Scripps Research Institute
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Scientist wins $3 million renewal of one of longest-running NIH grants to Scripps Research
2. Scripps Research Institute scientists develop antidote for cocaine overdose
3. Scripps Research Institute Professor Gerald F. Joyce elected to American Academy of Arts & Sciences
4. Scripps Research Institute scientists find promising vaccine targets on hepatitis C virus
5. Scripps Research discoveries lead to newly approved drug for infant respiratory distress syndrome
6. Scripps Florida scientists awarded $3 million to develop new, more effective pain treatments
7. Scripps Florida team awarded nearly $1.5 million to develop potent new HIV inhibitors
8. Scripps Research alumnus wins International Science and Engineering Visualization Challenge
9. Heat and cold damage corals in their own ways, Scripps study shows
10. Scripps Research team proves plausibility of new pathway to lifes chemical building blocks
11. Scripps Research scientists provide new understanding of chronic pain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scripps research scientists find anticonvulsant drug helps marijuana smokers kick the habit
(Date:8/20/2015)... Aug. 20, 2015   Sensory, Inc ., ... the user experience and security of consumer electronics ... announced that its TrulySecure™ is the ... to be FIDO Certified™. The FIDO ... with the FIDO UAF (Universal Authentication Framework) 1.0 ...
(Date:8/18/2015)... , Aug. 18, 2015  Navitas today ... contributor to the Submission Content Management webinar ... a non-profit forum. Dedicated to the Implementation of ... neutral platform for industry, vendors, health authorities, ... and work towards a standard method of ...
(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions ... the entire spectrum of clinical research, is proud to ... the company,s comprehensive SaaS-based eClinical technology platform, has led ... the first two quarters of 2015.   Q2 2015 ... largest quarters measured by contract value sold in the ...
Breaking Biology News(10 mins):TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3MedNet Solutions Experiences Explosive Corporate Growth 2
... China and San Diego, CA BGI, the world,s ... privately held biotechnology company that utilizes a proven metabolic ... design of new products and processes for the life ... the genomic sequence of the Chinese hamster ovary (CHO) ...
... kill a plant may actually make it stronger. After ... plants grow bigger and faster and reproduce more successfully ... report that one secret to these plants, post-traumatic triumph ... again and again without undergoing cell division. ...
... Research Park, working with colleagues in China, have developed ... to breeding the improved varieties of crop needed to ... complicated genome of oilseed rape they have been able ... for predictive breeding. , Traditional breeding involves crossing ...
Cached Biology News:Genome of CHO-K1 provides new insights into optimization of biopharmaceutical protein production 2Genome of CHO-K1 provides new insights into optimization of biopharmaceutical protein production 3Some plants duplicate their DNA to overcome adversity 2Dissecting the genomes of crop plants to improve breeding potential 2
(Date:8/27/2015)... CA (PRWEB) , ... August 27, 2015 , ... ... unique opportunity for venture capital funds, investment firms and animal health companies to ... Forum have raised $160 million. Several have also received licensing agreements or distribution ...
(Date:8/27/2015)... /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC Market: ... Holding Company Limited (Biohaven), announced today that dosing ... BHV-0223, a glutamate modulating agent. Biohaven filed an ... obtained clearance from the U.S. Food and Drug ... holds 54% equity interest in Biohaven, a private ...
(Date:8/27/2015)... Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced its results ... complete second quarter financial statements and MD&A have been filed on ... per shareThree-months ended , Six -months endedJune 30 , June 30 ... 2014 Revenue , 4,709 , 2,459 ... 1,656 , 56 , 3,188 , ...
(Date:8/27/2015)... ... ... Inc. Magazine released its annual list of the 5,000 fastest-growing privately held ... the three years through 2014. Being named to the Inc. 5000 list designates a ... , “We are thrilled to make the Inc. 5000 list for 2015,” stated ...
Breaking Biology Technology:VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4BIOREM Reports $718,000 Net Earnings for the Second Quarter 2BIOREM Reports $718,000 Net Earnings for the Second Quarter 3iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3
... /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) announced today that ... Rodman & Renshaw Annual Global Investment Conference taking place in London ... , , ... 5:15 a.m. Eastern Daylight Time ) on Tuesday, May 18 at ...
... PRINCETON, N.J. , May 12 ... or the Company), a late-stage biopharmaceutical company, announced ... a randomized, double-blind, placebo-controlled Phase 2 clinical trial ... disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT) ...
... Fisheries Science Center placed 61 satellite tags on fur seals, ... will allow researchers and the public to track the movements ... during our summer. "We typically observe these animals during ... go during the winter when weather conditions and ice make ...
Cached Biology Technology:Soligenix Announces Completion of Patient Enrollment in Phase 2 Acute GVHD Prevention Clinical Trial 2Soligenix Announces Completion of Patient Enrollment in Phase 2 Acute GVHD Prevention Clinical Trial 3Soligenix Announces Completion of Patient Enrollment in Phase 2 Acute GVHD Prevention Clinical Trial 4Soligenix Announces Completion of Patient Enrollment in Phase 2 Acute GVHD Prevention Clinical Trial 5